News /
events

Corporate

Job Advertisement: R&D Software Manager – Technology and Innovation at Symcel

Read More
Conference

7th October 2024

PDA Pharmaceutical Microbiology Conference 2024

Join us at the PDA Pharmaceutical Microbiology Conference 2024 in Washington DC.

Read More
Conference

25th November 2024

ATMP Sweden

We'll be at ATMP Sweden 2024 in Malmö.

Read More
Corporate

8th February 2024

Next-Gen Microbiome and Probiotics

Read More
Corporate

12th October 2023

Symcel Appoints Pia van der Zee as Chief Commercial Officer to Spearhead Growth in Emerging Clinical Markets

Read More
Corporate

14th July 2023

Welcome to the team - Kasper Nørskov Kragh

Read More
Corporate

6th April 2023

Symcel Awarded Grant to Develop Fast Diagnostics for Joint Infections

Read More
Corporate

18th October 2022

NEW PUBLICATION: Bacteria control their metabolism when going into biofilm formation

Read More
Corporate

12th October 2022

Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis

Read More
Corporate

7th October 2022

Invited to speak at the United States Pharmacopeia on probiotics

Read More
Corporate

5th October 2022

Symcel establishes US operation with headquarters in Boston

Read More
Corporate

11th May 2022

NEW PUBLICATION: calScreener shows efficacy of antibiotic treatments against group A streptococci in a complex mammalian cell model

Read More
Corporate

11th May 2022

One step closer to a pill for weight loss without diet or exercise

Read More
Corporate

11th May 2022

NEW PUBLICATION: Giving antibiotics another chance in Cystic Fibrosis

Read More
Corporate

11th May 2022

Symcel raises 105 MSEK to develop rapid diagnostics to combat severe infections

Read More